<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Bionity.COM News</title>
    <link>http://www.bionity.com/news/e/</link>
    <description>The latest news about trends and developments in the biotech, pharma and life science industries</description>
    <language>en-us</language>
    <image>
      <title>Bionity.COM</title>
      <url>http://www.bionity.com/pictures/bionity/BionityCOM.gif</url>
      <link>http://www.bionity.com/?language=e</link>
    </image>
    <item>
      <title>Cancer geneticist Janet Davison Rowley to receive $500,000 Gruber genetics prize</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102836/?WT.mc_id=ca0068</link>
      <description>Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation. She is being honored with the prestigious international award for discoveries of recurrent ...</description>
      <pubDate>Fri, 03 Jul 2009 10:00:04 GMT</pubDate>
    </item>
    <item>
      <title>GENEART Again Honored with "BAVARIA'S BEST 50" Award</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102908/?WT.mc_id=ca0068</link>
      <description>GENEART AG is among the 50 most dynamic companies in Bavaria and has been awarded "BAVARIA'S BEST 50" by the Bavarian State Ministry for the third time. Since its market entry in 2000, GENEART evolved to the world market leader in synthetic gene ...</description>
      <pubDate>Fri, 03 Jul 2009 10:00:04 GMT</pubDate>
    </item>
    <item>
      <title>Study shows that a combination of common genetic variations can lead to schizophrenia</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102837/?WT.mc_id=ca0068</link>
      <description>A multi-national group of investigators, including a scientist at the University of North Carolina at Chapel Hill, has discovered that nearly a third of the genetic basis of schizophrenia may be attributed to the cumulative actions of thousands of ...</description>
      <pubDate>Fri, 03 Jul 2009 10:00:04 GMT</pubDate>
    </item>
    <item>
      <title>Lu AA24530 shows positive results in major depressive disorder phase II study</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102910/?WT.mc_id=ca0068</link>
      <description>H. Lundbeck A/S announced positive headline results from a dose finding clinical trial with the compound Lu AA24530 for the treatment of major depressive disorder (MDD). The primary objective of the study was to compare the efficacy of three doses ...</description>
      <pubDate>Fri, 03 Jul 2009 10:00:04 GMT</pubDate>
    </item>
    <item>
      <title>Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102829/?WT.mc_id=ca0068</link>
      <description>Johnson &amp; Johnson announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab), is ...</description>
      <pubDate>Fri, 03 Jul 2009 04:00:03 GMT</pubDate>
    </item>
    <item>
      <title>IOP announces 2009 award winners</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102823/?WT.mc_id=ca0068</link>
      <description>Successful business applications such as drug screening technologies, flat-panel displays and solar-cell designs are amongst the achievements in physics recognised by the Institute of Physics' (IOP) 2009 awards along with leading research in a wide ...</description>
      <pubDate>Fri, 03 Jul 2009 04:00:03 GMT</pubDate>
    </item>
    <item>
      <title>Alzheimer's research yields potential drug target</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102831/?WT.mc_id=ca0068</link>
      <description>Scientists at UC Santa Barbara and several other institutions have found laboratory evidence that a cluster of peptides may be the toxic agent in Alzheimer's disease. Scientists say the discovery may lead to new drugs for the disease. In an article ...</description>
      <pubDate>Fri, 03 Jul 2009 04:00:02 GMT</pubDate>
    </item>
    <item>
      <title>Genetically engineered mice yield clues to 'knocking out' cancer</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102833/?WT.mc_id=ca0068</link>
      <description>Deleting two genes in mice responsible for repairing DNA strands damaged by oxidation leads to several types of tumors, providing additional evidence that such stress contributes to the development of cancer. That's the conclusion of a study in DNA ...</description>
      <pubDate>Fri, 03 Jul 2009 04:00:02 GMT</pubDate>
    </item>
    <item>
      <title>NIST issues human milk and blood serum SRMs for contaminant measurements</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102834/?WT.mc_id=ca0068</link>
      <description>Responding to scientists' need to measure organic contaminants in human body fluids, the National Institute of Standards and Technology (NIST) has recently made four new Standard Reference Materials (SRMs) available for purchase. Developed in ...</description>
      <pubDate>Fri, 03 Jul 2009 04:00:02 GMT</pubDate>
    </item>
    <item>
      <title>Comprehensive and User-Friendly Biotech News, Constantly Updated</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102846/?WT.mc_id=ca0068</link>
      <description>BionityCOM, an online information portal provided by Chemie.DE Information Service GmbH, now offers the most comprehensive coverage of news for the biotech and pharma industries in Europe. Bionity.COM's specialist editorial team repeatedly updates ...</description>
      <pubDate>Thu, 02 Jul 2009 22:00:00 GMT</pubDate>
    </item>
    <item>
      <title> Pharming confirms positive results from final analysis of Rhucin studies</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102810/?WT.mc_id=ca0068</link>
      <description>Pharming Group NV announced that, as part of the activities for the regulatory submission files, it has now also completed the final analysis of its Rhucin® randomised placebo-controlled studies. The results confirm the positive and consistent ...</description>
      <pubDate>Thu, 02 Jul 2009 10:00:03 GMT</pubDate>
    </item>
    <item>
      <title>André Choulika succeeds Philippe Pouletty as Chairman of France Biotech</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102815/?WT.mc_id=ca0068</link>
      <description>At the Annual General Meeting, the members of France Biotech voted to elect their governing bodies, in accordance with the organization's statutes. The newly elected Administrative Council then appointed André Choulika as Chairman. He succeeds the ...</description>
      <pubDate>Thu, 02 Jul 2009 10:00:03 GMT</pubDate>
    </item>
    <item>
      <title>ChemWerth, Inc. announces Wuhan Pharmaceutical Factory passes FDA inspection</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102820/?WT.mc_id=ca0068</link>
      <description>ChemWerth Inc. reported the Wuhan Pharmaceutical Factory facility has passed an FDA overseas inspection with a two point 483 being issued. ChemWerth and Wuhan are collaborating to develop APIs for the U.S. and other regulated markets overseas. Wuhan ...</description>
      <pubDate>Thu, 02 Jul 2009 10:00:03 GMT</pubDate>
    </item>
    <item>
      <title>LANXESS disinfectant effective against swine flu viral strain</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102817/?WT.mc_id=ca0068</link>
      <description>A recent study carried out on behalf of LANXESS has demonstrated the effectiveness of the disinfectant Preventol CD 601 against the swine flu viral strain. "The test results from Giessen University show that Preventol CD 601 can also play a major ...</description>
      <pubDate>Thu, 02 Jul 2009 10:00:03 GMT</pubDate>
    </item>
    <item>
      <title>Study identifies biomarker that safely monitors tumor response to new brain cancer treatment</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102782/?WT.mc_id=ca0068</link>
      <description>A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. The finding, reported in Clinical Cancer ...</description>
      <pubDate>Thu, 02 Jul 2009 10:00:03 GMT</pubDate>
    </item>
    <item>
      <title>MorphoSys and the University of Melbourne File New Patent Applications in MOR103 Program</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102809/?WT.mc_id=ca0068</link>
      <description>MorphoSys AG and the University of Melbourne announced an agreement to cooperate on investigating new therapeutic applications for MorphoSys's MOR103 program. MOR103, a HuCAL antibody against human GM-CSF (Granulocyte macrophage-colony stimulating ...</description>
      <pubDate>Thu, 02 Jul 2009 10:00:03 GMT</pubDate>
    </item>
    <item>
      <title>Kelvin Lee winner of Biochemical Engineering Journal Young Investigator Award</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102684/?WT.mc_id=ca0068</link>
      <description>The Biochemical Engineering Journal and the ECI Biochemical Engineering Conferences have announced that Kelvin H. Lee, Gore Professor of Chemical Engineering at the University of Delaware and Director of the Delaware Biotechnology Institute, is the ...</description>
      <pubDate>Thu, 02 Jul 2009 10:00:03 GMT</pubDate>
    </item>
    <item>
      <title>Evotec Announces the Successful Completion of the First Phase I Study with EVT 401</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102769/?WT.mc_id=ca0068</link>
      <description>Evotec AG announced the successful completion of the first Phase I study with its P2X7 receptor antagonist EVT 401. EVT 401 is a small molecule drug candidate and a potentially novel approach to orally treat inflammatory conditions such as ...</description>
      <pubDate>Thu, 02 Jul 2009 04:00:03 GMT</pubDate>
    </item>
    <item>
      <title>Researchers of VTT, the University of Turku and the University of Heidelberg discover new information on spreading of cancer</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102774/?WT.mc_id=ca0068</link>
      <description>A joint research group of VTT Technical Research Centre of Finland and the University of Turku, led by Professor Johanna Ivaska, has discovered a mechanism lung cancer cells use when spreading into the body to form metastases. The study has been ...</description>
      <pubDate>Thu, 02 Jul 2009 04:00:03 GMT</pubDate>
    </item>
    <item>
      <title>Thermo Fisher Scientific Wins Microsoft Pharmaceutical and Life Sciences Innovation Award in Informatics</title>
      <category>Bionity.COM News</category>
      <link>http://www.bionity.com/news/e/102776/?WT.mc_id=ca0068</link>
      <description>Thermo Fisher Scientific Inc. announced that it has been named the winner of the Microsoft Corporation 2009 Pharmaceutical and Life Sciences Innovation Award in the Discovery and Product Innovation category, for the second consecutive year. The ...</description>
      <pubDate>Thu, 02 Jul 2009 04:00:03 GMT</pubDate>
    </item>
    <copyright>© 2009, Chemie.DE Information Service GmbH.</copyright>
  </channel>
</rss>
